| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 850,700 | 900,000 | 1,302,800 | 1,316,700 | | Cost of Revenue | 45,800 | 37,400 | 24,400 | 101,700 | | | Gross Profit |
-
| 862,600 | 1,278,400 | 1,215,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 249,700 | 293,900 | 162,600 | 913,300 | | Non Recurring |
-
| 692,400 |
-
| (712,200) | | Others | 973,600 | 885,900 | 817,400 | 621,900 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,009,600) | 298,400 | 392,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (418,400) | (989,600) | 278,400 | 392,000 | | Interest Expense | 648,000 | 596,200 | 632,700 | 692,900 | | Income Before Tax | (1,066,400) | (1,585,800) | (354,300) | (300,900) | | Income Tax Expense | (33,100) | 12,700 | 8,000 | (162,900) | | Minority Interest |
-
| 700 | (500) | 10,100 | | | | Net Income From Continuing Ops | (1,033,500) | (1,617,800) | (342,800) | (127,900) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (57,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,033,500) | (1,617,800) | (342,800) | (184,900) | | Preferred Stock And Other Adjustments | (41,200) | (61,600) | (60,400) | (20,400) | | | Net Income Applicable To Common Shares | ($1,074,500) | ($1,679,400) | ($403,200) | ($205,300) |
|
0.24% Nasdaq 
0.24%
Income Statement
